Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to... see more

Recent & Breaking News (GREY:TBPMQ)

Tetra Bio-Pharma Provides Update on U.S. and Canadian Regulatory Activities

GlobeNewswire December 19, 2019

Tetra Bio-Pharma Signs Definitive Commercialization Agreement for CAUMZ(TM) in Portugal With Azevedos Indústria Farmacêutica, S.A

GlobeNewswire December 16, 2019

Tetra Bio-Pharma Provides Update on its Hepatocellular Carcinoma Drug HCC011

GlobeNewswire December 10, 2019

Tetra Bio-Pharma Receives FDA Orphan Drug Designation for Hepatocellular Carcinoma

GlobeNewswire December 4, 2019

Tetra Bio-Pharma Signs Definitive Commercialization Agreement for CAUMZ(TM) in Mexico With Alternavida S.A.

GlobeNewswire December 2, 2019

Tetra Bio-Pharma Confirms Submission of Two OTC DIN Applications to Health Canada

GlobeNewswire November 26, 2019

FDA Approves Advancement of PPP001 Clinical Trial Previously Discontinued

GlobeNewswire November 25, 2019

Tetra Bio-Pharma Secures Financing for Hemp Energy Drink Business

GlobeNewswire November 18, 2019

Tetra Bio-Pharma Joins BIOTECanada

GlobeNewswire November 13, 2019

Tetra Bio-Pharma Confirms Regulatory Strategy of Lead Product CAUMZ(TM) and Strengthens Management Team

GlobeNewswire November 11, 2019

Tetra Bio-Pharma Provides Management Update on Tetra Natural Health's Commercial Activities

GlobeNewswire October 30, 2019

Tetra Bio-Pharma Provides Management Update on Commercializing its Inhalation Drug Caumz®

GlobeNewswire October 21, 2019

Tetra Bio-Pharma Provides Regulatory Update for Its CAUMZ(TM) Kit

GlobeNewswire October 3, 2019

Tetra Bio-Pharma Announces Joint Venture with Thorne and Onegevity Health to Form CB2 Therapeutics

GlobeNewswire August 21, 2019

Tetra Bio-Pharma Engages LifeSci Advisors and LifeSci Public Relations as Strategic Partners

GlobeNewswire August 12, 2019

Tetra's Officers and Employees Participate in Private Placement

Canada NewsWire August 2, 2019

Tetra's Officers and Employees Participate in Private Placement

GlobeNewswire July 30, 2019

The New Hemp Energy Drink Will Be Offered to Consumers in 700 Additional Stores in Five Provinces

GlobeNewswire July 18, 2019

Tetra Bio-Pharma's Management Post Financing Corporate Update

GlobeNewswire July 18, 2019

The New Hemp Energy Drink Will Soon Be Available In More Than 500 Stores in Quebec

GlobeNewswire July 16, 2019